The Biostatistics Shared Resource supports the clinical, translational, and scientific research needs of the Duke Cancer Institute (DCI) with respect to study design, conceptualization of research projects, analytic methods sections of grants and protocols, scientific review of protocols, participation in the DSMP, case report form (CRF) design, analysis for manuscripts and abstracts, data management, and other critical research activities. These efforts are aligned with the DCI disease groups, with faculty and staff from the Department of Biostatistics and Bioinformatics partnering with disease groups, participating in research developmental meetings, and providing research methodological leadership to these efforts. The result of these alignments has been strengthened grant funding, high impact publications, and an enhanced research-training environment at DCI.
Additional resource: Clinical Trial Design Systems
The Biostatistics Shared Resource members have numerous types of statistical computing software available for the analytic needs of the DCI. These include but are not limited to SAS, R, Stata, StatXact, nQuery, PASS, Medidata Rave, Rave Balance, S-Plus, Matlab, Maple, and Mathematica. Most are available through University-based site licensing or through Departmental-based group licenses. DCI supports Medidata Rave and Balance to facilitate clinical research.
The majority of the Biostatistics Shared Resource efforts are dependent upon computing and associated infrastructure. The computing hardware infrastructure of the Biostatistics Shared Resource is comprised of dedicated hardware owned and managed by the DCI Bioinformatics Shared Resource and is further extended by hardware resources maintained by DCI Information Systems (IS), Duke University Office of Information Technology (OIT) and by the Duke Clinical & Translational Science Institute (CTSI).
DCI members have direct access to the Biostatistics Shared Resource through participation in programmatic research meetings, by contacting their Program Leader, or by contacting the Core Managing Director. Biostatistics faculty and staff regularly participate in the disease group research meetings, according to their assigned alignments. This enables the Biostatistics faculty and staff to remain aware of research priorities, allows participation in discussion of research directions, and allows for the appropriate planning regarding protocols, grants, manuscripts, and projects. For new DCI members, if there is not an assigned contact person, or if there is a research direction that is not sufficiently supported, then meetings are arranged to discuss needs and appropriate staffing for the research area. Terry Hyslop, PhD, then determines required resources, and identifies personnel to assure that the needs are met, with approval of resources provided by DCI Administration.
DCI members are not charged for collaboration with the Biostatistics Shared Resource. The expectation is that these services are provided to lay the foundation for long-term scientific collaborations between the DCI investigators and shared resource personnel that will lead to grant and federal and industry contract applications, as well as high-level publications. The shared resource staff and faculty are expected to be included as co-investigators on these grants and contracts, and co-authors on these publications, as the DCI support funds are primarily meant for research development purposes.
Shared Resource: Biostatistics
Some of the questions researchers at the DCI face every day include: How many patients of a rare cancer should be studied, and for how long, to estimate how well a treatment works? For rare diseases, how can a feasible design be formulated? What if the treatment is harmful or has side effects? Should fast- and slow-growing cancer types be lumped together or treated as separate categories? How can a researcher recruit underrepresented populations? And how can you assure that the data I collect will provide the information I will need to answer my question? More
Duke Cancer Institute constellates the world-class resources of Duke University, Duke Health and the Duke Comprehensive Cancer Center into a collaborative powerhouse. We are poised to drive a paradigm shift in the way long-established cancer centers and institutes have been waging this war.Learn More